Guideline Review: EASL Clinical Practice Guidelines: Drug-Induced Liver Injury (DILI)

Paul N. Brennan (Lead / Corresponding author), Peter Cartlidge, Thomas Manship, John F. Dillon

Research output: Contribution to journalReview articlepeer-review

1 Citation (Scopus)
30 Downloads (Pure)

Abstract

The European Association for the Study of the Liver has produced extensive guidelines for the investigation and management of drug-induced liver injury. Here, we provide a commentary and overview of some of the principle disease investigations and management that arise from these guideline recommendations.

Original languageEnglish
Pages (from-to)332-336
Number of pages5
JournalFrontline Gastroenterology
Volume13
Issue number4
Early online date29 Jul 2021
DOIs
Publication statusPublished - Jul 2022

Keywords

  • drug induced hepatotoxicity
  • drug induced liver injury
  • drug metabolism
  • drug toxicity

Fingerprint

Dive into the research topics of 'Guideline Review: EASL Clinical Practice Guidelines: Drug-Induced Liver Injury (DILI)'. Together they form a unique fingerprint.

Cite this